Status:
NOT_YET_RECRUITING
Modeling Clinical Outcomes in Gambling Addiction
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Gambling Disorder
Eligibility:
All Genders
18+ years
Brief Summary
Gambling disorder (GD) is recognized as an addictive disorder. Financial consequences of GD are often dramatic, inducing professional, familial, legal and medical repercussions and particularly mental...
Eligibility Criteria
Inclusion
- Patient, male or female, over 18 years old, consulting in one of the participating centers.
- DSM-5 criteria for gambling disorder at inclusion: at least 4 criteria present in the 12 months preceding the study.
- First treatment for gambling disorder or no treatment in the last 6 months (initiation or re-initiation of care).
Exclusion
- Unable to be reached by phone.
- Unable to use the internet.
- Patient under antiparkinsonian treatment of the dopaminergic family.
- Being treated with a drug that may trigger/increase symptoms of gambling disorder (e.g. dopamine agonist).
- Subject under guardianship.
Key Trial Info
Start Date :
September 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2030
Estimated Enrollment :
268 Patients enrolled
Trial Details
Trial ID
NCT06981546
Start Date
September 1 2025
End Date
September 1 2030
Last Update
May 20 2025
Active Locations (9)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Jen Minjoz, CHU de Besançon
Besançon, France, 25030
2
Service Universitaire d'Addictologie de Lyon (SUAL), CH Le Vinatier
Bron, France, 69500
3
Service Universitaire d'Addictologie de Lyon (SUAL), Groupement Hospitalier Est
Bron, France, 69500
4
Service Universitaire d'Addictologie, CHU de Clermont-Ferrand
Clermont-Ferrand, France, 63000